Beacon Investment Advisory Services Inc. Increases Stock Holdings in Kenvue Inc. $KVUE

Beacon Investment Advisory Services Inc. lifted its holdings in Kenvue Inc. (NYSE:KVUE) by 67.0% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 467,108 shares of the company’s stock after purchasing an additional 187,426 shares during the period. Beacon Investment Advisory Services Inc.’s holdings in Kenvue were worth $7,581,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Saybrook Capital NC raised its position in Kenvue by 33.1% in the third quarter. Saybrook Capital NC now owns 479,304 shares of the company’s stock worth $7,779,000 after acquiring an additional 119,255 shares during the period. MBL Wealth LLC purchased a new stake in Kenvue in the 3rd quarter worth $415,000. Avanza Fonder AB lifted its holdings in Kenvue by 19.8% in the 3rd quarter. Avanza Fonder AB now owns 224,995 shares of the company’s stock worth $3,652,000 after purchasing an additional 37,259 shares in the last quarter. VCI Wealth Management LLC bought a new position in Kenvue in the 3rd quarter worth approximately $672,000. Finally, Brookstone Capital Management increased its holdings in Kenvue by 7.1% in the 3rd quarter. Brookstone Capital Management now owns 232,396 shares of the company’s stock valued at $3,772,000 after acquiring an additional 15,340 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Kenvue

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The shares were purchased at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. The trade was a 13.27% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.68% of the stock is owned by company insiders.

Kenvue Price Performance

KVUE opened at $17.20 on Friday. The firm has a market capitalization of $32.95 billion, a PE ratio of 22.93 and a beta of 0.60. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The business’s 50-day moving average is $16.44 and its two-hundred day moving average is $18.73.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business had revenue of $3.76 billion for the quarter, compared to the consensus estimate of $3.83 billion. During the same period in the prior year, the firm posted $0.28 earnings per share. The business’s quarterly revenue was down 3.5% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were paid a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. The ex-dividend date was Wednesday, November 12th. Kenvue’s payout ratio is presently 110.67%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on KVUE shares. Bank of America dropped their price objective on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft set a $18.00 target price on Kenvue in a research note on Friday, October 24th. JPMorgan Chase & Co. decreased their price target on Kenvue from $24.00 to $21.00 and set an “overweight” rating for the company in a research note on Friday, October 10th. Redburn Partners set a $22.00 price objective on Kenvue in a research report on Friday, September 26th. Finally, Evercore ISI set a $18.00 price objective on shares of Kenvue in a research report on Tuesday, October 28th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and twelve have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $20.23.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.